CA2238275A1 - Metalloproteinase inhibitors - Google Patents

Metalloproteinase inhibitors

Info

Publication number
CA2238275A1
CA2238275A1 CA002238275A CA2238275A CA2238275A1 CA 2238275 A1 CA2238275 A1 CA 2238275A1 CA 002238275 A CA002238275 A CA 002238275A CA 2238275 A CA2238275 A CA 2238275A CA 2238275 A1 CA2238275 A1 CA 2238275A1
Authority
CA
Canada
Prior art keywords
metalloproteinase inhibitors
co2h
alkyl
heterocyclic ring
nhco2r
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002238275A
Other languages
French (fr)
Other versions
CA2238275C (en
Inventor
Fionna Mitchell Martin
Christopher Norman Lewis
Mark Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9523937.2A external-priority patent/GB9523937D0/en
Priority claimed from GBGB9610985.5A external-priority patent/GB9610985D0/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/GB1996/002877 external-priority patent/WO1997019053A1/en
Publication of CA2238275A1 publication Critical patent/CA2238275A1/en
Application granted granted Critical
Publication of CA2238275C publication Critical patent/CA2238275C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of general formula (I) wherein X is a -CO2H, -NH(OH)CHO or -CONHOH group; R1 is a cylcoalkyl, cycloalkenyl or non-aromatic heterocyclic ring containing up to 3 heteroatoms, any of which may be (i) substituted by one ore more substituents selected from C1-C6 alkyl, C2-C6 alkenyl, halo, cyano (-CN), -CO2H, -CO2R, -CONH2, -CONHR, -CON(R)2, -OH, -OR, oxo-, -SH, -SR, -NHCOR, and -NHCO2R
wherein R is C1-C6 alkyl or benzyl and/or (ii) fused to a cycloalky or heterocyclic ring; and R2, R3. R4 and R5 are as defined in the specification are matrix metalloproteinase inhibitors.
CA002238275A 1995-11-23 1996-11-21 Metalloproteinase inhibitors Expired - Fee Related CA2238275C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9523937.2A GB9523937D0 (en) 1995-11-23 1995-11-23 Metalloproteinase inhibitors
GB9523937.2 1995-11-23
GB9610985.5 1996-05-24
GBGB9610985.5A GB9610985D0 (en) 1996-05-24 1996-05-24 Metalloproteinase inhibitors
PCT/GB1996/002877 WO1997019053A1 (en) 1995-11-23 1996-11-21 Metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
CA2238275A1 true CA2238275A1 (en) 1997-05-29
CA2238275C CA2238275C (en) 2005-10-04

Family

ID=35395922

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002238275A Expired - Fee Related CA2238275C (en) 1995-11-23 1996-11-21 Metalloproteinase inhibitors

Country Status (1)

Country Link
CA (1) CA2238275C (en)

Also Published As

Publication number Publication date
CA2238275C (en) 2005-10-04

Similar Documents

Publication Publication Date Title
AU7633096A (en) Metalloproteinase inhibitors
ZA944884B (en) Derivatives of valproic acid amides and 2-valproenoic acid amides method of making and use thereof as anticonvulsant agent
JPS55313A (en) Imidazole derivative
AU7077894A (en) Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
IE801070L (en) Phenylsulphonamides
ZA9610418B (en) Phenylimidazolidines containing in particular a nitrooxy or carbonyloxy radical, preparation process and intermediates, use as medicaments, new uses and pharmaceutical compositions.
NZ333550A (en) Matrix metalloproteinase inhibitors for inhibiting the release of TNF
TW252979B (en)
CA2238275A1 (en) Metalloproteinase inhibitors
NO960168D0 (en) Method of Preparation of HIV Protease Inhibitors
CA2136008A1 (en) Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation
MY131544A (en) Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
CA2208032A1 (en) Substituted amidinonaphthyl ester derivative
IL116646A0 (en) Antifungal fusacandins
ES2059275A1 (en) Halogenophenoxy compounds
EP0414913A4 (en) P-aminophenol derivative and production and application thereof
YU15596A (en) Process for synthesis of compounds by reductive animation
CA2207443A1 (en) Tricyclic compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed